- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- Why Cardiac Monitoring Belongs at the Foundation of Your Service Line Strategy: A Conversation with Amanda Maples, RN, BSN, MHA
- Baptist Health Floyd taps chief medical officer from Asante
- Journey to joy: Leveraging national burnout data — executive insights and innovations from leading health systems
- Washington provider cuts cancellations to 19% with scheduling model
- Increasing home care capabilities to decrease hospitalizations
- ‘We want to be known as your best partner’: UnitedHealthcare leaders talk provider tensions, prior auth cuts
- Cohen Veterans Network opens 1st Kansas mental health clinic
- Mississippi treatment center sees 35% rise in alcohol admissions
- St. Jude CFO to step down for West Virginia role
- FDA backs 3 psychedelic drug studies for mental illness
- FDA backs 3 psychedelic drug studies for mental illness
- Providence launches 12 Epic AI tools
- Staffing legislation, Medicaid and more: 4 dentistry updates in Maine
- Wisconsin hospital president to retire after 51-year career
- HCA still expects up to $900M hit from ACA headwinds
- Vitana Pediatric & Orthodontic Partners adds New York practice
- Parkview Health to open outpatient facility
- 3 rising cardiovascular leaders to know
- The best ASCs for colonoscopy, endoscopy in the Northeast: US News
- How dental M&A is evolving in 2026
- Missouri physician indicted for healthcare fraud, illegal prescriptions
- The dental developments keeping leaders up at night
- Spine group to open new ASC
- States look to enhance Medicaid dental programs: 4 notes
- Weill Cornell study points to new IBD treatment strategy
- Alabama hospital to expand outpatient services
- Inpatient vs. outpatient spine surgery: What do patients prefer?
- Trump administration to change coverage for breakthrough cardiology devices
- Dr. Eugene Braunwald, the ‘father of modern cardiology,’ dies at 96
- 3 dental companies laying off employees
- 4 DSOs making headlines
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- Lawmakers introduce bipartisan legislation to improve access, quality of care in Medicare Advantage plans
- HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- UnitedHealthcare, Aetna, Cigna tout progress to standardize prior authorization as part of industry-wide commitment
- Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval
- FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs
- Industry Voices—Hospitals are very online, but what happens when they're plunged into 'digital darkness'?
- Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
- Genentech wants ‘All Eyes on DME’ as it taps Damon Wayans for humor-laced campaign
- Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs
- Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO
- Patients less confident than ever about health choices: survey
- Pfizer drafts Fernando Mendoza as new face of its ‘game of inches’ cancer campaign
- Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs
- Acadia taps interim CFO amid finance chief’s departure
- Connecticut fines 5 insurers over alleged mental health parity violations
- The legislation that could change dentistry’s trajectory
- How dental AI is addressing 3 of dentistry’s most pressing issues
- Dental technology company secures $22M investment
- Meadows Behavioral Health center rebrands, expands services
- Justice Department reclassifies marijuana products: What it means for healthcare
- AI-powered prior authorizations for Medicare have greatly delayed care, Washington state hospitals say
- Can Trump’s deal with the UK become a model for similar drug price agreements?
- Cincinnati Children’s appoints psychiatry division director
- Northwell Health unveils toolkit for gun violence prevention in healthcare settings
- FTC files suit over telemarketing scheme selling fake PPO insurance
- What is psilocybin? Inside Trump’s push for psychedelic treatments
- Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
- Molina strikes 'prudent' tone on 2026 outlook amid positive signs on Medicaid spending
- Regeneron unveils latest 'most favored nation' drug pricing deal with White House
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
- UPDATED: Roche Q1 earnings suffer from currency headwinds with hits and misses across the board
- FDA citizen petition calls on agency to tighten up CRL disclosure practices
- With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity
- Telehealth provider Him & Hers adds all FDA-approved GLP-1s to platform
- CMS, FDA announce new program to speed up Medicare coverage of breakthrough medical devices
- With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- New Treatment, Dato-DXd, Improves Survival for Aggressive Breast Cancer
- ER Study Finds Major Gaps in Measles Immunity
- Most Americans Worried About Brain Health, But Few Know How To Protect It
- IVF 'Add On' Procedure With Hormone Human Chorionic Gonadotropin (hCG) Doesn't Work, Evidence Review Concludes
- More than 60% of Americans using AI tools for medical information: survey
- Evonik to pump €80M into Slovakia production facility, add 50 jobs
- OpenAI launches ChatGPT for Clinicians, a free AI tool for physicians, NPs and pharmacists
- Deerfield trots into pharma sales software space with CRM-enhancing tool
- Merck’s new AI commercial strategy ‘reimagining engagement with HCPs’
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Conservative think tank Paragon Health calls its shots on hospital policy reform
- Amazon One Medical launches GLP-1 program integrated with primary care
- CDC Report on COVID Vaccine Blocked From Publication
- Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
- RFK Jr. continues congressional hearing appearances to talk White House budget plan
- RFK Jr. Won't Commit to CDC Nominee's Vaccine Decisions
- Pentagon Drops Flu Vaccine Requirement For U.S. Military
- AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs
- Zocdoc partners with Yelp to allow real-time scheduling
- CMS delays Part D GLP-1 model amid skepticism from insurers
- CMS delays Part D GLP-1 model amid skepticism from insurers
- Healthcare finance leaders cite federal funding uncertainty, Medicaid cuts as top concerns
- Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
- Male Infertility Linked To Cancer Risk
- Video Game Training Sharpens ER Doctors’ Split-Second Decisions
- Hidden Belly Fat Linked to Bladder Control in Women
- Mind-Controlled Bionic Suit Lets Paralyzed Patients Feel Every Step
- Napping Linked To Higher Risk Of Death Among Seniors, Study Finds
- Oak HC/FT backs Courier Health's $50M series B to build out AI for the biopharma patient experience
- Elevance Health seeing shift to bronze tier in ACA plans
- Community Health Systems attributes Q1 volumes stumble to consumers' macroeconomic fears, payers' prior auth denials
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- Amperos Health secures $16M in series A funding, unveils AI-native denial management solution
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Why UnitedHealth Group is betting big on doulas
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Remarks at the Options Market Structure Roundtable
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
Denmark may seem to be an odd exemplar for health care policy, but they are home to Novo Nordisk A/S, the worlds largest and most sophisticated manufacturer of pharmaceutical products and provider of health care services. The revolving door of the Indenrigs-og Sundhedsministeriet (Danish Ministry of Health) is connected to Novo Nordisk:
https://thehill.com/policy/healthcare/5656844-trump-rfk-child-immunization-schedule-overhaul/
HHS to announce overhaul to child vaccine schedule, aligning with Denmark
By Joseph Choi - December 19, 2025The Trump administration is planning to announce an overhaul to the childhood immunization schedule early next year, recommending fewer shots and aligning U.S. policy with that of Denmark.
A source familiar with the matter told NewsNation correspondent Libbey Dean that a new vaccination schedule to be released next year would recommend fewer shots, “aligning more with Denmark’s vaccination schedule.”
The Department of Health and Human Services (HHS) was scheduled to make an announcement on “children’s health” Friday, but it was postponed because of competing plans from the White House, which is expected to announce new deals to lower drug prices Friday afternoon.
HHS Secretary Robert F. Kennedy Jr. and his allies have routinely cited Denmark as an ideal in terms of vaccine policy that the U.S. should emulate. Denmark’s immunization schedule does not recommend seasonal vaccines for respiratory viruses like RSV, COVID-19 and the flu. The country also doesn’t recommend vaccinating against hepatitis B for all infants or against chickenpox.
During a recent meeting of the Advisory Committee on Immunization Practices (ACIP) for the Centers for Disease Control and Prevention (CDC), members of the panel sympathetic to Kennedy repeatedly pointed to Denmark’s immunization policy, with a presentation on the differences between American and Danish vaccine schedules included in the agenda.
The presentation noted the U.S. recommends 72 childhood vaccination doses targeting 18 diseases, while Denmark only recommends 11 doses targeting 10 diseases.
Pro-vaccine voices critical of Kennedy’s frequent comparisons to Denmark argue that the small European nation does not make for a fair comparison. The country has a population of roughly 6 million people distributed across an area similar to the state of Maryland. Denmark also has universal health care system with free comprehensive health services.
Maybe not. Big Pharma has weighed in:
https://www.politico.com/news/2025/12/20/rfk-kennedy-danish-vaccine-schedule-denmark-00701999
RFK Jr. wanted to endorse the Danish vaccine schedule. He was forced to pull back.
Legal and political concerns prompted the health department to cancel a planned announcement on Friday, officials said.
By Tim Röhn - December 20, 2025Health Secretary Robert F. Kennedy Jr. came within hours of publicly promoting Denmark’s childhood vaccine schedule as an option for American parents — before legal and political concerns got in the way.
A senior HHS official told POLITICO that a press conference set for Friday was canceled at the last minute after the HHS Office of the General Counsel said it would invite a lawsuit the administration could lose.
A second senior official at the Department of Health and Human Services confirmed the press conference, which HHS had publicly announced, was to be about the Danish schedule. The second official said it was canceled because it was deemed politically risky.
Billed as an “announcement regarding children’s health,” Kennedy was to appear alongside his top agency heads and Tracy Beth Høeg, the Food and Drug Administration’s top drug regulator. Høeg touted the Danish schedule at a vaccine advisory committee meeting earlier this month.
HHS canceled the event Thursday evening, hours after announcing it.
Andrew Nixon, an HHS spokesperson, called accounts of the cancellation that didn’t come directly from the department “pure speculation” in a statement.
HHS officials skeptical of moving to the Danish schedule, which recommends immunization for only 10 of the 17 diseases on the U.S. list, were relieved it was never publicly recommended, the first official said. The internal confusion and disagreement follow similar management bungling within HHS’ Food and Drug Administration that has frustrated the White House.
On Dec. 5, President Donald Trump signed a presidential memorandum titled “Aligning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries.” The memorandum directed HHS and the Centers for Disease Control and Prevention, one of its subagencies that sets the vaccine schedule, to review peer-country best practices for vaccines recommended for all children and, if those practices were judged superior, to update the U.S. schedule while preserving access to vaccines already available. In the memorandum, Trump mentioned Denmark, Japan and Germany as examples of countries that recommend fewer shots than the U.S.
According to the first official, Kennedy and his top aide, Stefanie Spear, helped sell the peer-country framing to West Wing officials as the clearest way to turn internal vaccine skepticism into a signed White House directive. Spear is Kennedy’s principal deputy chief of staff and senior counselor.
Kennedy is a longtime vaccine skeptic who believes the U.S. schedule has grown too quickly, has not been tested in its entirety for adverse effects, and is a likely cause of rising autism rates. Numerous studies have not found a link between vaccines and the neurological disorder that now affects one in 31 U.S. children, up from one in 150 two decades ago.
Experts in the condition, which affects the ability to communicate, say expanded diagnostic criteria and awareness are responsible for most of that rise. The condition’s cause is usually genetic, they believe, but researchers are studying possible environmental causes.
HHS has made it a priority to learn more about what causes autism and why diagnoses are rising. The department’s research arm, the National Institutes of Health, announced an Autism Data Science Initiative on May 27 and has awarded around $50 million to fund 13 projects investigating potential causes.
In April, Kennedy promised to reveal autism’s cause in September, but HHS later said it would reveal preliminary findings early next year. Autism researchers, who have studied the condition for years, have called that unrealistic.
The first indication Kennedy might be considering the slimmer Danish schedule, which excludes vaccines for chickenpox, the flu, hepatitis A and B, meningitis, respiratory syncytial virus and rotavirus, came earlier this month during the CDC’s Advisory Committee on Immunization Practices meeting in Atlanta. Høeg presented a slide deck titled “U.S. vs. Danish Vaccine Schedule,” which the CDC posted among the meeting presentations.
The department then circulated Høeg’s presentation to top officials at HHS, the first senior official said. In the ensuing debate, Høeg’s supporters proposed offering the Danish schedule as a government-recommended alternative to the U.S. one.
The first senior official and two others inside HHS familiar with internal discussions, all of whom were granted anonymity to reveal deliberations they were not authorized to discuss publicly, said proponents of the Danish schedule felt that offering it would help restore trust in vaccines; many Americans were turned off by Covid-era vaccine mandates and claims that Covid shots would halt transmission that turned out to be incorrect, they argued.
The three officials said the view of proponents inside the administration was that the Danish schedule could be pitched as a “reset” that might convince hesitant parents to vaccinate their kids.
Critics inside the administration, the officials said, argued the plan to recommend the Danish schedule was not rigorous and science-based — and that promoting it publicly would invite criticism. Rather than restoring trust, they said it could undermine it by signaling doubt about the need for, and safety of, routine immunization.
Going forward without laying the scientific groundwork or going through normal regulatory processes could also make the department vulnerable to lawsuits, the HHS general counsel’s office argued, according to the first senior official. Mike Stuart, who was a U.S. attorney in West Virginia in Trump’s first term, now is HHS general counsel.
The American Academy of Pediatrics, which represents doctors who care for children, along with other physician and public health groups, has already sued HHS for changes it made earlier this year to Covid vaccine recommendations, saying the department violated rules governing how regulatory changes are made. That case is pending in federal district court in Boston.
HHS has stopped recommending Covid boosters for previously vaccinated people under 65 who are not at high risk of the disease. Instead, the department says Americans should talk to their doctor and make a shared decision.
"Science Based" has become shorthand for making someone a lot of money.
HHS' new, Danish inspired, childhood vaccine schedule was announced today:
HHS dramatically overhauls childhood vaccine schedule, downgrading advice for flu, meningitis, other shots
Federal officials say the U.S. schedule should be more in line with recommendations in other countries. Public health experts say the goal belies differences between health systems and disease prevalence.
By Lauren Gardner | January 5, 2026The Department of Health and Human Services announced Monday a dramatic overhaul of the childhood vaccine schedule, weakening recommendations for flu and three other shots in the name of aligning U.S. policies with certain European countries.
The shift, which was telegraphed weeks ago before being paused amid legal and political concerns, comes after President Donald Trump directed Health Secretary Robert F. Kennedy Jr. in December to review the childhood schedule and consider revising it to align with those of other developed countries, most of which recommend fewer shots.
Kennedy, a longtime anti-vaccine activist before entering government, has criticized the American schedule for years as bloated compared to other nations. He has claimed associations between the schedule’s expansion since the late 1980s and growing rates of chronic conditions from autism to allergies — despite scientific consensus rejecting such links.
The Centers for Disease Control and Prevention will soften its advice for vaccines targeting rotavirus, meningococcal disease, hepatitis A and influenza, which the agency reported Monday has already killed nine American children so far this winter season.
Those shots will no longer be universally recommended but advised under a concept known as shared clinical decision-making, which emphasizes conversations between health care providers and patients before choosing to vaccinate. The agency shifted to such an approach last year for Covid-19 and hepatitis B vaccine recommendations for most populations.
The respiratory syncytial virus antibody injection for infants will be recommended for “certain high-risk groups or populations,” HHS said, but it’s unclear how officials are defining that group.
“At a time when parents, pediatricians and the public are looking for clear guidance and accurate information, this ill-considered decision will sow further chaos and confusion and erode confidence in immunizations,” American Academy of Pediatrics President Andrew Racine said in a statement. “This is no way to make our country healthier.”
The CDC also changed its recommendation Monday for the HPV vaccine to a single dose, despite FDA approval for a two- and three-dose series depending on a patient’s age.
The CDC will continue to recommend that kids be vaccinated against measles, mumps, rubella, polio, whooping cough, tetanus, diphtheria and human papillomavirus or HPV, diseases for which HHS said there’s “international consensus” in favor of immunization. The agency will also maintain its recommendation for the chickenpox vaccine, which some countries don’t embrace but others are increasingly advising.
With Monday’s changes, the core U.S. immunization schedule has been whittled down by about a third, to 11 shots from 18 in 2024. HHS Deputy Secretary Jim O’Neill, who’s currently acting as the CDC’s leader, signed a memo Monday directing the agency to make the changes effective immediately.
In doing so, the agency circumvented its own external advisory panel, the Advisory Committee on Immunization Practices, which has historically vetted schedule changes as new products are approved and safety and effectiveness data emerge. HHS also did not provide evidence in support of its decisions outside of an assessment conducted by two agency officials who have promoted European nations’ approaches to vaccines.
The presidential memo cited Denmark, Germany and Japan as “peer, developed” nations with slimmer schedules. Denmark’s schedule, which has been a chief point of comparison for HHS officials, does not recommend any of the shots that are being moved to shared clinical decisionmaking.
“The U.S. is a global outlier among peer nations in the number of target diseases included in its childhood vaccination schedule and in the total number of recommended vaccine doses,” Tracy Beth Hoeg, the FDA’s acting director for the Center for Drug Evaluation and Research, and Martin Kulldorff, chief science and data officer for HHS’ Office of the Assistant Secretary for Planning and Evaluation, wrote in an assessment upon which the department is basing its changes.
The assessment found that public trust in routine pediatric vaccines plummeted in the U.S. amid pandemic-era policies like school closures and immunization mandates in some areas of the country. It calls for softening some longstanding recommendations for illnesses that Hoeg and Kulldorff suggested aren’t as serious or widespread in a bid to restore public trust.
“The backdrop for this then meant that we needed to take action to increase the public confidence in the vaccine schedules,” a senior HHS official told reporters on a call Monday featuring several department officials, all of whom declined to comment on the record.
But vaccine and public health experts have said such a move belies fundamental differences between the fragmented U.S. health system and other countries — especially those in Europe — that provide universal care to their residents. Disease prevalence also varies across countries, and those experts say the longstanding U.S. recommendations reflect pathogens that commonly circulate here.
Many of the decisions other countries “make about vaccine schedules are not based on the burden of disease, but rather on cost,” Sean O’Leary, chair of the American Academy of Pediatrics’ committee on infectious diseases, told reporters.
The CDC’s vaccine advice has traditionally fallen into the same nuanced categories as those outlined Monday by Kennedy’s HHS: recommendations for all, recommendations for certain populations or high-risk groups, and individualized recommendations based on conversations between providers and patients.
A “recommended” vaccine means vaccination is the default, though the federal government doesn’t mandate vaccines for children to enter childcare facilities or schools. That power is left to the states.
Historically, the CDC only amended its immunization schedules after receiving input from the ACIP, which also has exclusive authority to direct changes to a federal safety-net program offering free vaccines to un- and underinsured children. Kennedy universally overhauled the panel last year to include several members who share his vaccine skepticism; the committee had already acted to weaken recommendations for Covid and hepatitis B vaccines before Monday’s announcement.
The senior HHS official said Monday’s changes don’t mean the advisory panel is being disbanded even though the department has circumvented its role in announcing the new changes.
“We will continue to pose important questions for them,” he said. “We will continue to update the schedule based on their advice, their thorough examination of particular vaccines, two or three at a time.”
HHS officials said all vaccines the CDC had recommended as of the end of 2025 will still be fully covered by federal insurers like Medicaid and by Affordable Care Act insurance plans. “This means that insurance will continue to cover more vaccines for children in the U.S. than in peer nations, where insurance generally only pays for recommended vaccines,” the department said in a fact sheet.
The AAP sued Kennedy last summer over the ACIP overhaul. O’Leary said he couldn’t comment on whether the group would amend the lawsuit to include Monday’s action.
O’Leary said Kennedy “does have a lot of leeway” to influence vaccine recommendations. But he and other public health experts said lawmakers should consider whether HHS is subverting congressional intent by making fundamental vaccine policy changes outside the traditional structure.
“The power to prevent the downstream consequences, that may end up being up to Congress,” he said.
Sen. Bill Cassidy (R-La.), who leads the chamber’s health policy committee and who cast the deciding vote last year recommending Kennedy’s confirmation, posted on X Monday that the CDC vaccine schedule “IS NOT A MANDATE,” though he didn’t call out the secretary by name.
“It’s a recommendation giving parents the power,” he said in his post. “Changing the pediatric vaccine schedule based on no scientific input on safety risks and little transparency will cause unnecessary fear for patients and doctors, and will make America sicker.”
The immediate public reaction of high profile Michigan health care providers is derogatory:
Michigan doctors criticize changes to US childhood vaccination schedule
By Eli Newman - January 5, 2026
- The CDC is scaling back the number of shots the public agency recommends for American children, moving to 11 from 17
- Doctors and public health experts in Michigan say the decision is politically motivated and will sow ‘chaos’ among patients and their families
- The Michigan Department of Health and Human Services issued an order last year to follow the immunization guidance laid out by the country’s leading physician groups
Some Michigan physicians and public health experts say the federal government’s decision to scale back its recommendations for childhood vaccinations could be dangerous and sow “chaos” among families and their doctors.
The US Centers for Disease Control and Prevention announced Monday it would update the immunization schedule for American youth by reducing the number of recommended routine shots to 11 from 17. The decision is tied to President Donald Trump’s order last year to review vaccine policy in other countries and update the American recommendations accordingly.
“After an exhaustive review of the evidence, we are aligning the US childhood vaccine schedule with international consensus while strengthening transparency and informed consent,” Robert F. Kennedy Jr., secretary of US Health and Human Services, said in a statement announcing the changes. “This decision protects children, respects families, and rebuilds trust in public health.”
But several Michigan doctors say the decision does the exact opposite.
“It will create confusion in the minds of parents and the American public,” said Dr. Anand Parekh, chief health policy officer at the University of Michigan School of Public Health.
A former US Health and Human Services deputy assistant secretary, Parekh said the CDC’s decision is “not based on science” and reflects the preferences of individual policymakers at the helm of the government. He said the change could be “quite harmful” in dissuading families from vaccination against preventable illnesses.
Following the announcement, the Michigan Department of Health and Human Services reiterated its support of vaccines as a successful tool to prevent the spread of infectious diseases, pointing to decisions made last year to maintain their use in the state among a shifting stance from federal policymakers.
In December, Michigan’s chief medical executive, Dr. Natasha Bagdasarian, issued a standing recommendation to follow the childhood immunization standards provided by the country’s leading physician groups, saying at the time that many public health experts “are not in agreement with recent federal vaccine recommendations.”
The American Academy of Pediatrics and American Academy of Family Physicians have criticized the immunization policy changes undertaken during the Trump administration and maintain childhood vaccination schedules that recommend more shots than the federal government.
Dr. Joseph Fakhoury, president of the Michigan chapter of the American Academy of Pediatrics, said the federal government’s decision would bring about “chaos” for families.
“It’s, truthfully, incredibly disappointing,” Fakhoury told Bridge. “Even those that already have a pretty strong confidence in immunizations and a good trusting relationship with their physician team … I worry more that it just will continue to erode that confidence.”
Vaccines for measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus and chickenpox will remain recommended for children under the updated federal policy. Shots to prevent influenza, hepatitis A and B, rotavirus, meningococcal disease and COVID-19 have shifted to a “shared decision-making” category, in which the government recommends consultation with a health care provider.
“All vaccines currently recommended by CDC will remain covered by insurance without cost sharing,” Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz said in a statement. “No family will lose access. This framework empowers parents and physicians to make individualized decisions based on risk, while maintaining strong protection against serious disease.”
Those representing many of Michigan’s health insurance companies say they are not aware of any plans to change coverage.
“Customers’ access to essential vaccinations of their choice, as well as other forms of preventive care, is crucial to ensuring affordable health care and positive health outcomes,” said Brian Mills, spokesperson for the Michigan Association of Health Plans. “If customers have any questions about their current vaccination coverage, they’re encouraged to contact their health plan.”
Some vaccine proponents had worried the CDC would stop recommending the measles, mumps and rubella (MMR) vaccine after some, including President Donald Trump, have tried to link the shot to autism in children. While the American Psychiatric Association and other major physician groups discredit the claim, the CDC’s website now says the link can’t be ruled out.
Recent polling suggests 1 in 6 parents are skipping or delaying shots for their children, with skepticism toward vaccine efficacy and safety more prevalent among the GOP. According to Pew Research, 52% of Republicans support the school mandate for the MMR vaccine.
Oh, but it's the people who are confused!
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2026/01/06/vaccines-state
MDHHS issues statement about federal changes to childhood vaccine schedule
LANSING, Mich. – Following updates to the U.S. childhood immunization schedule made today by Deputy Secretary of Health and Human Services Jim O’Neill, in his role as acting director of the Centers for Disease Control and Prevention, the Michigan Department of Health and Human Services issued the following statement:
“For decades, vaccines have played a critical role in the prevention and control of infectious diseases and significant reductions in childhood illnesses and fatalities.
On Thursday, Dec. 18, Michigan’s Chief Medical Executive Dr. Natasha Bagdasarian issued a Standing Recommendation advising health care providers and families to follow the child and adolescent immunization schedule produced by the American Academy of Pediatrics (AAP) or the American Academy of Family Physicians (AAFP). We continue to stand by that recommendation.”
The underlying scientific evidence remains unchanged and continues to support the full AAP and AAFP vaccination schedules for children. Families should still be able to access the full range of childhood immunizations as recommended by the AAP and AAFP to protect their children from serious diseases.
All vaccines, including those moved to shared clinical decision-making, remain covered with no out-of-pocket cost by Affordable Care Act-regulated private insurance plans and federal coverage programs such as Medicaid and the Vaccines for Children program, as HHS affirmed in its announcement.
Bagdasarian noted that the changes announced today may create confusion for families and clinicians regarding school vaccine requirements, clinical workflows and the supply and use of combination vaccines.
“MDHHS will continue to provide clear guidance, backed by science to help protect Michigan families,” Bagdasarian said.
# # #
Notice the federal/state divide?
The state is allying with private organizations. Parents are more free to make healthcare choices.
I love the direction this is going for healthcare freedom.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






